Tuba Esfandyari

1.4k total citations
34 papers, 981 citations indexed

About

Tuba Esfandyari is a scholar working on Gastroenterology, Surgery and Oncology. According to data from OpenAlex, Tuba Esfandyari has authored 34 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Gastroenterology, 10 papers in Surgery and 6 papers in Oncology. Recurrent topics in Tuba Esfandyari's work include Gastrointestinal motility and disorders (13 papers), Virus-based gene therapy research (4 papers) and Gastroesophageal reflux and treatments (4 papers). Tuba Esfandyari is often cited by papers focused on Gastrointestinal motility and disorders (13 papers), Virus-based gene therapy research (4 papers) and Gastroesophageal reflux and treatments (4 papers). Tuba Esfandyari collaborates with scholars based in United States, United Kingdom and Canada. Tuba Esfandyari's co-authors include Michael Camilleri, Alan R. Zinsmeister, Duane D. Burton, Kari Baxter, Richard W. McCallum, Faris Farassati, Irene Busciglio, Irene Ferber, Michael F. Vaezi and Vidya Bodempudi and has published in prestigious journals such as Gastroenterology, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Tuba Esfandyari

33 papers receiving 955 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tuba Esfandyari United States 17 435 298 194 177 157 34 981
Koji Yakabi Japan 19 171 0.4× 338 1.1× 234 1.2× 69 0.4× 129 0.8× 68 991
F Izbéki Hungary 17 448 1.0× 342 1.1× 209 1.1× 26 0.1× 171 1.1× 39 930
Akiyoshi Mizumoto Japan 26 632 1.5× 1.1k 3.6× 250 1.3× 51 0.3× 145 0.9× 99 1.9k
Martin Katschinski Germany 16 240 0.6× 637 2.1× 272 1.4× 57 0.3× 201 1.3× 32 1.3k
M.L. Fitzpatrick United Kingdom 13 218 0.5× 209 0.7× 158 0.8× 28 0.2× 107 0.7× 23 770
Gábor Sütő Hungary 15 136 0.3× 246 0.8× 149 0.8× 45 0.3× 130 0.8× 64 697
R. Nustede Germany 22 135 0.3× 715 2.4× 150 0.8× 32 0.2× 193 1.2× 76 1.3k
A M Blackburn United Kingdom 14 249 0.6× 294 1.0× 144 0.7× 24 0.1× 231 1.5× 22 1.1k
A. Schafmayer Germany 17 135 0.3× 573 1.9× 73 0.4× 30 0.2× 118 0.8× 71 1.0k
Karin Tømmerås Norway 13 43 0.1× 180 0.6× 197 1.0× 76 0.4× 129 0.8× 18 710

Countries citing papers authored by Tuba Esfandyari

Since Specialization
Citations

This map shows the geographic impact of Tuba Esfandyari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuba Esfandyari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuba Esfandyari more than expected).

Fields of papers citing papers by Tuba Esfandyari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tuba Esfandyari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuba Esfandyari. The network helps show where Tuba Esfandyari may publish in the future.

Co-authorship network of co-authors of Tuba Esfandyari

This figure shows the co-authorship network connecting the top 25 collaborators of Tuba Esfandyari. A scholar is included among the top collaborators of Tuba Esfandyari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tuba Esfandyari. Tuba Esfandyari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abell, Thomas L., Braden Kuo, Tuba Esfandyari, et al.. (2023). A randomized, double‐blind, placebo‐controlled, phase 2b study of the efficacy and safety of velusetrag in subjects with diabetic or idiopathic gastroparesis. Neurogastroenterology & Motility. 35(4). e14523–e14523. 9 indexed citations
2.
Terai, Kaoru, Zohreh Sanaat, Roya Dolatkhah, et al.. (2018). A Novel Oncolytic Herpes Capable of Cell-Specific Transcriptional Targeting of CD133± Cancer Cells Induces Significant Tumor Regression. Stem Cells. 36(8). 1154–1169. 14 indexed citations
3.
Borrego-Diaz, Emma, Tuba Esfandyari, Kun Wang, et al.. (2014). RalA signaling pathway as a therapeutic target in hepatocellular carcinoma (HCC). Molecular Oncology. 8(5). 1043–1053. 33 indexed citations
4.
McCallum, Richard W., Anthony Lembo, Tuba Esfandyari, et al.. (2013). Phase 2b, randomized, double‐blind 12‐week studies of TZP ‐102, a ghrelin receptor agonist for diabetic gastroparesis. Neurogastroenterology & Motility. 25(11). e705–17. 73 indexed citations
5.
Fan, Fang, et al.. (2013). The Utility of Lower Endoscopic Ultrasound-guided Fine Needle Aspiration for the Diagnosis of Benign and Malignant Pelvic Diseases. Journal of Clinical Gastroenterology. 48(2). 127–130. 13 indexed citations
6.
Ejskjær, Niels, John M. Wo, Tuba Esfandyari, et al.. (2012). A phase 2a, randomized, double‐blind 28‐day study of TZP‐102 a ghrelin receptor agonist for diabetic gastroparesis. Neurogastroenterology & Motility. 25(2). e140–50. 62 indexed citations
7.
Wang, Kun, Vidya Bodempudi, Emma Borrego-Diaz, et al.. (2012). Inhibition of Mesothelin as a Novel Strategy for Targeting Cancer Cells. PLoS ONE. 7(4). e33214–e33214. 41 indexed citations
8.
Borrego-Diaz, Emma, et al.. (2012). Pro-Oncogenic Cell Signaling Machinery as a Target for Oncolytic Viruses. Current Pharmaceutical Biotechnology. 13(9). 1742–1749. 5 indexed citations
9.
Patel, Vijay, Emma Borrego-Diaz, Kun Wang, et al.. (2012). Inhibition of RalA signaling pathway in treatment of non-small cell lung cancer. Lung Cancer. 77(2). 252–259. 33 indexed citations
10.
Reddymasu, Savio, et al.. (2011). Are Endoscopic Ultrasonography Imaging Characteristics Reliable for the Diagnosis of Small Upper Gastrointestinal Subepithelial Lesions?. Journal of Clinical Gastroenterology. 46(1). 42–45. 21 indexed citations
11.
Camilleri, Michael, Y. Ringel, William L. Hasler, et al.. (2010). Wireless pH‐motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation. Neurogastroenterology & Motility. 22(8). 874–874. 159 indexed citations
12.
Esfandyari, Tuba, Ayalew Tefferi, Tommy Alain, et al.. (2009). Transcription factors down‐stream of Ras as molecular indicators for targeting malignancies with oncolytic herpes virus. Molecular Oncology. 3(5-6). 464–468. 10 indexed citations
13.
Pan, Weihong, Vidya Bodempudi, Tuba Esfandyari, & Faris Farassati. (2009). Utilizing Ras Signaling Pathway to Direct Selective Replication of Herpes Simplex Virus-1. PLoS ONE. 4(8). e6514–e6514. 33 indexed citations
14.
Esfandyari, Tuba, Susan C. Abraham, & Amindra S. Arora. (2007). Gastrointestinal plasmacytoma that caused anemia in a patient with multiple myeloma. Nature Clinical Practice Gastroenterology & Hepatology. 4(2). 111–115. 12 indexed citations
15.
Camilleri, Michael, et al.. (2007). Comparison of mathematical methods for calculating colonic compliance in humans: power exponential, computer‐based and manual linear interpolation models. Neurogastroenterology & Motility. 20(4). 330–335. 16 indexed citations
16.
Esfandyari, Tuba, Michael Camilleri, Irene Ferber, et al.. (2006). Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo‐controlled study. Neurogastroenterology & Motility. 18(9). 831–838. 94 indexed citations
17.
Esfandyari, Tuba, Michael Camilleri, Duane D. Burton, et al.. (2006). Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women. Neurogastroenterology & Motility. 18(10). 911–918. 92 indexed citations
18.
Esfandyari, Tuba & Gavin C. Harewood. (2006). Value of a negative colonoscopy in patients with non‐specific gastrointestinal symptoms. Journal of Gastroenterology and Hepatology. 22(10). 1609–1614. 9 indexed citations
19.
Esfandyari, Tuba, et al.. (2002). Dysphagia: a cost analysis of the diagnostic approach. The American Journal of Gastroenterology. 97(11). 2733–2737. 42 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Koji Yakabi Breakdown of academic impact, for papers by F Izbéki Breakdown of academic impact, for papers by Akiyoshi Mizumoto Breakdown of academic impact, for papers by Martin Katschinski Breakdown of academic impact, for papers by M.L. Fitzpatrick Breakdown of academic impact, for papers by Gábor Sütő Breakdown of academic impact, for papers by R. Nustede Breakdown of academic impact, for papers by A M Blackburn Breakdown of academic impact, for papers by A. Schafmayer Breakdown of academic impact, for papers by Karin Tømmerås
Rankless by CCL
2026